Crenezumab (MABT 5102A; RG 7412) is a fully humanized monoclonal antibody designed to target and bind various forms of amyloid beta (A??), including soluble, oligomeric, and fibrillar aggregates. This antibody is extensively utilized in the study of Alzheimer's disease, providing a critical tool for researchers investigating the pathogenesis and potential therapeutic interventions for this neurodegenerative disorder.
Crenezumab (MABT 5102A; RG 7412) is a fully humanized monoclonal antibody designed to target and bind various forms of amyloid beta (A??), including soluble, oligomeric, and fibrillar aggregates. This antibody is extensively utilized in the study of Alzheimer's disease, providing a critical tool for researchers investigating the pathogenesis and potential therapeutic interventions for this neurodegenerative disorder.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
